Next Article in Journal
Synthesis and Comparative Evaluation of Novel Cationic Amphiphile C12-Man-Q as an Efficient DNA Delivery Agent In Vitro
Next Article in Special Issue
Native V. californicum Alkaloid Combinations Induce Differential Inhibition of Sonic Hedgehog Signaling
Previous Article in Journal
Crystal Structure of LSD1 in Complex with 4-[5-(Piperidin-4-ylmethoxy)-2-(p-tolyl)pyridin-3-yl]benzonitrile
Previous Article in Special Issue
Cholinesterase Inhibition Activity, Alkaloid Profiling and Molecular Docking of Chilean Rhodophiala (Amaryllidaceae)
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Mahimbrine A, a Novel Isoquinoline Alkaloid Bearing a Benzotropolone Moiety from Mahonia imbricata

1
School of Pharmacy, Zunyi Medical University, Zunyi 563006, China
2
School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
*
Author to whom correspondence should be addressed.
Molecules 2018, 23(7), 1539; https://doi.org/10.3390/molecules23071539
Submission received: 17 May 2018 / Revised: 14 June 2018 / Accepted: 22 June 2018 / Published: 26 June 2018
(This article belongs to the Special Issue Advances in Plant Alkaloid Research)

Abstract

:
A novel isoquinoline alkaloid, mahimbrine A, possessing a rare benzotropolone framing scaffold, was isolated from the endemic plant of Mahonia imbricata. Its structure was established on the basis of extensive spectroscopic analysis. A plausible biosynthetic route of mahimbrine A was proposed. Mahimbrine A showed no antimicrobial activity at the concentration of 1 mg/mL.

1. Introduction

Mahonia imbricata Ying et Boufford, as one of the endemics of seed plants in China, is a perennial shrub of the family Berberidaceae, distributed only in Guizhou and Yunan provinces of Southwest China [1]. Plants of the genus Mahonia have long been used as a traditional medicine to treat tuberculosis, periodontitis, dysentery, pharyngolaryngitis, eczema, and wounds [2]. Previous chemical investigations on this genus have involved a series of chemical constituents. Among these constituents, alkaloids are principal constituents of the genus Mahonia [3,4,5]. As part of an ongoing research program to isolate and determine structures of secondary metabolites from medicinal endemic plants of southwestern China [6,7], we performed a phytochemical study on M. imbricate. As a result, a novel isoquinoline alkaloid, possessing a rare benzotropolone substituent, was isolated (Figure 1). Its structure was established by means of spectroscopic analysis including one- and two-dimensional NMR spectroscopy. Moreover, the hypothetical biosynthetic route was proposed. Mahimbrine A was tested against four gram-positive bacterial strains and four gram-negative bacteria.

2. Results and Discussion

2.1. Structure Elucidation of Mahimbrine A

Mahimbrine A was obtained as a brown gum. Its molecular formula was established as C24H23NO5 on the basis of the HR-ESI-MS ([M + H]+ at m/z 406.1632, calcd. 406.1649 and [2M + H]+ at m/z 811.3226, calcd. 811.3225), which requires 14 degrees of unsaturation. The IR absorptions at 3434 and 1633 cm−1 suggested the presence of hydroxyl and carbonyl groups in the molecule. UV absorptions at λmax 230 and 288 nm deduced the presence of an α, β-unsaturated carbonyl moiety [8]. The 1H, 13C NMR and HSQC spectra of mahimbrine A (Table 1) showed 24 carbon resonances due to a methine at δH 2.91 (2H, m), δC 25.8; four methoxyl groups at δH 3.60 (3H, s), 3.93 (6H, s), 3.94 (3H, s), δC 56.2, 56.2, 56.2, 61.8; a methine at δH 3.90 (1H, m), 4.03 (1H, m), δC 47.9; a 1,2,3,4-tetrasubstituted phenyl ring moiety at δH 7.04 (1H, d, J = 9.1 Hz), 7.28 (1H, d, J = 9.1 Hz), δC 153.7, 148.4, 1131.5, 129.2, 128.8, 114.5; a 1,2,4,5-tetrasubstituted phenyl ring moiety at δH 6.57 (1H, s), 6.78 (1H, s), δC 151.8, 147.9, 131.4, 121.9, 110.6, 110.6; a carbonyl at δC 188.4; and an unsaturated system at δH 8.20 (1H, d, J = 13.0 Hz), 6.87 (1H, dd, J = 13.0, 2.7 Hz), 6.74 (1H, d, J = 2.7 Hz), δC 168.4, 148.8, 134.9, 133.6, 133.5.
The obvious HMBC correlations (Figure 2) from H-3 to C-1, C-4a, H-4 to C-5, C-4a, C-8a, H-5 to C-4, C-7, C-8a, H-8 to C-1, C-4a, C-6, OCH3 to C-6 and OCH3 to C-7 evidenced the presence of a dihydroisoquinoline unit with two methoxyl groups located at C-6 and C-7, respectively. The HMBC correlations of H-9′ to C-7′ (δC 188.4), C-4′a, H-8′ to C-6′, C-9′a (δC 131.5), and H-6′ to C-4′a (δC 129.2), C-8′a, established the presence of a tropolone moiety, which was further verified by the vicinal coupling constants of H-8′/H-9′ (J = 13.0 Hz) [9]. Moreover, the HMBC correlations of H-9′ to C-1′, C-4′a, H-4′ to C-2′, C-5′, C-9′a confirmed the tropolone moiety and 1,2,3,4-tetrasubstituted phenyl ring moiety connected via a bridged bond at C-4′a and C-9′a. Similarly, two methoxyl groups at C-1′ and C-2′ were also assigned. The HMBC correlations of H-6′ to C-1, C-4′a and H-4′ to C-5 indicated that the dihydroisoquinoline unit and benzotropolone unit were connected to each other by C-1 and C-5′. Thus, the final structure of this compound was determined and named mahimbrine A.

2.2. Plausible Biogenetic Pathway

A plausible biogenetic pathway for mahimbrine A was postulated (Scheme 1). As a precursor, naphthylacetic acid and dopamine via condensation reaction to give an amide intermediate 1 [10], which subsequently undergoes a Bischler-Napieralski reaction to generate intermediate 2 [11]. Intermediate 2 is then oxidized to yield intermediate 3 [12]. Intermediate 3 can spontaneously convert to its enol form. This enol intermediate then undergoes ring expansion rearrangement to give intermediate 4 [13], which is finally methylated to get mahimbrine A.

2.3. Antimicrobial Activity

The antimicrobial activity of mahimbrine A was evaluated against four gram-positive bacterial strains Staphylococcus aureus ATCC 6538, Micrococcus luteus CMCC 28001, Staphylococcus epidermidis ATCC 12228, and Bacillus subtilis ATCC 21332; and four gram-negative bacteria Pseudomonas aeruginosa ATCC 27853, Escherichia coli ATCC 25922, Salmonella typhimurium ATCC 14028, and Enterobacter aerogenes ATCC 13048, by a microdilution titre technique; neither was active [14]. Gentamicin and streptomycin were used as positive controls. Discs containing 10 μL DMSO solutions were used as a negative control. All tests were performed in triplicate.

3. Experimental Section

3.1. General Procedures

UV spectra were recorded on a Perkin-Elmer Lambda 35 UV-VIS spectrophotometer (Perkin-Elmer, Waltham, MA, USA). IR spectra were measured on a PerkinElmer one FT-IR spectrometer (KBr) (Perkin-Elmer, Waltham, MA, USA). 1D and 2D-NMR spectra were recorded on a Bruker-Ascend-400 or an Agilent DD2400-MR instrument using TMS as the internal reference. HR-ESI-MS spectra were measured on a LTQ Orbitrap XL mass spectrometer (Thermo Scientific, Waltham, MA, USA). Column chromatography was performed using silica gel (300–400 mesh, Qingdao marine Chemical Ltd., Qingdao, China). Semi-preparative HPLC was performed on LC3000 system (Beijing ChuangXingTongHeng Science And Technology Co., Ltd., Beijing, China) equipped with an ODS column (5 μm, i.d. 10 mm × 250 mm, YMC). Original raw data of 1D, 2D NMR spectra and HR-ESI-MS of mahimbrine A are available in the supplementary materials.

3.2. Plant Material

The plant was collected from Loushanguan in Zunyi City, People’s Republic of China, in October 2013, and identified as Mahonia imbricata by Prof. Jian-Wen Yang, Zunyi Medical University. A voucher specimen (20131020) was deposited with the Herbarium of the School of Pharmacy, Zunyi Medical University.

3.3. Extraction and Isolation

The air-dried and finely ground stems of Mahonia imbricata (30 kg) were extracted with 90% ethanol for three times at room temperature (5 days each). The ethanol extract was evaporated under reduced pressure to get a crude extract (2 kg), which was further suspended in acidic water (pH 3–4) and then filtered to obtain the filtrate. The filtrate was alkalized to pH 9–10 and extracted successively with CHCl3 and n-BuOH (each 3 times), respectively. The CHCl3 extract was subjected to silica gel column chromatography (80 mm × 600 mm, 1400 g, 300–400 mesh), eluted with a gradient of CHCl3/MeOH (v/v = 100:1–1:100) to afford ten fractions (A–J). Fraction C was separated by Sephadex LH-20 column chromatography (CHCl3/MeOH = 1:1) and divided into 15 subfractionses (fraction A.1–A.15). Mahimbrine A (3.8 mg) was obtained from fraction A.6 by sempipreparative HPLC (MeOH/H2O = 55:45, flow rate 4 mL/min).

3.4. Spectral Data

Mahimbrine A: brown gum; UV (CH3OH): 230 (2.68), 288 (2.43); IR (KBr): 3434, 2920, 1633, 1590, 1512, 1384, 1292, 1026, 810; 1H and 13C NMR data, Table 1. HR-ESI-MS: m/z 406.1632 [M + H]+, C24H24NO5+, calcd. 406.1649; m/z 811.3226 [2M + H]+, calcd. 811.3225.

4. Conclusions

In conclusion, mahimbrine A has been isolated from the endemic plant of Mahonia imbricate and its chemical structure has been elucidated. It displays an interesting structure with a dihydroisoquinoline moiety bound to a rare benzotropolone ring system. The structure of mahimbrine A was elucidated by HR-ESI-MS, 1D, 2D NMR and a biosynthetic pathway was proposed. Mahimbrine A did not show antimicrobial activity at the tested concentration of 1 mg/mL. The interesting structural architecture of this natural product might find further applications.

Supplementary Materials

1D, 2D NMR spectra and HR-ESI-MS of mahimbrine A are available online.

Author Contributions

M.-S.Z. conceived and designed the experiments; Y.D. isolation and purification of mahimbrine A from Mahonia imbricata; S.-B.F. performed the biological activity tests. D.-L.G. characterization of 2D NMR spectra; S.-J.X. identification of mahimbrine A and writing of the manuscript.

Acknowledgments

This work was financially supported by the National Natural Sciences Foundation of China (No. 31560102), and the United Fund of Guizhou Province, Zunyi Medical University and Zunyi City (QKHJ-LKZ [2010] 26).

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Ying, J.S.; Cheng, D.Z. Flora of China; Science Press: Beijing, China, 2001; Volume 20, p. 242. [Google Scholar]
  2. He, J.M.; Mu, Q. The medicinal uses of the genus Mahonia in traditional Chinese medicine: An ethnopharmacological, phytochemical and pharmacological review. J. Ethnopharmacol. 2015, 175, 668–683. [Google Scholar] [CrossRef] [PubMed]
  3. Müller, K.; Ziereis, K. The antipsoriatic Mahonia aquifolium and its active constituents; I. Pro- and antioxidant properties and inhibition of 5-lipoxygenase. Planta Med. 1994, 60, 421–424. [Google Scholar] [CrossRef] [PubMed]
  4. Račková, L.; Májeková, M.; Košt’Álová, D.; Štefek, M. Antiradical and antioxidant activities of alkaloids isolated from Mahonia aquifolium. Structural aspects. Bioorg. Med. Chem. 2004, 12, 4709–4715. [Google Scholar] [CrossRef] [PubMed]
  5. Hsieh, T.J.; Chia, Y.C.; Wu, Y.C.; Chen, Z.Y. Chemical Constituents from the Stems of Mahonia japonica. J. Chin. Chem. Soc. 2004, 51, 443–446. [Google Scholar] [CrossRef]
  6. Xiao, S.J.; Lei, X.X.; Xia, B.; Xiao, H.P.; He, D.H.; Fang, D.M.; Qi, H.Y.; Chen, F.; Ding, L.S.; Zhou, Y. Two novel norlignans from Gymnotheca chinensis. Tetrahedron Lett. 2014, 55, 2869–2871. [Google Scholar] [CrossRef]
  7. Xiao, S.J.; Lei, X.X.; Xia, B.; Xu, D.Q.; Xiao, H.P.; Xu, H.X.; Chen, F.; Ding, L.S.; Zhou, Y. Two novel polycyclic spiro lignans from Gymnotheca involucrate. Tetrahedron Lett. 2014, 55, 5949–5951. [Google Scholar] [CrossRef]
  8. He, D.H.; Ding, L.S.; Xu, H.X.; Lei, X.X.; Xiao, H.P.; Zhou, Y. Gymnothelignans A–O: Conformation and absolute configuration analyses of lignans bearing tetrahydrofuran from Gymnotheca chinensis. J. Org. Chem. 2012, 77, 8435–8443. [Google Scholar] [CrossRef] [PubMed]
  9. Kuroyanagi, M.; Shirota, O.; Sekita, S.; Nakane, T. Transannular cyclization of (4S,5S)-germacrone-4, 5-epoxide into guaiane and secoguaiane-type sesquiterpenes. Nat. Prod. Comm. 2012, 7, 441–446. [Google Scholar]
  10. Tam, E.K.W.; Liu, L.Y.; Chen, A.Q. 2-Furanylboronic acid as an effective catalyst for the direct amidation of carboxylic acids at room temperature. Eur. J. Org. Chem. 2015, 2015, 1100–1107. [Google Scholar] [CrossRef]
  11. Nimgirawath, S.; Lorpitthaya, R.; Wanbanjob, A.; Taechowisan, T.; Shen, Y.M. Total synthesis and the biological activities of (+/−)-norannuradhapurine. Molecules 2008, 14, 89–101. [Google Scholar] [CrossRef] [PubMed]
  12. Daniel, L.C.; Paresh, M.T.; Matthew, F.B.; Badawi, M.M. Chiral auxiliary mediated pictet-spengler reactions: Asymmetric syntheses of (−)-laudanosine, (+)-glaucine and (−)-xylopinine. Tetrahedron 1997, 53, 16327–16340. [Google Scholar]
  13. Xin, M.; Bugg, T.D.H. Biomimetic formation of 2-tropolones by dioxygenase-catalysed ring expansion of substituted 2,4-cyclohexadienones. Chembiochem 2010, 11, 272–276. [Google Scholar] [CrossRef] [PubMed]
  14. Cheng, D.D.; Zhang, Y.Y.; Gao, D.M.; Zhang, H.M. Antibacterial and anti-inflammatory activities of extract and fractions from Pyrrosia petiolosa (Christ et Bar.) Ching. J. Ethnopharmacol. 2014, 155, 1300–1305. [Google Scholar] [CrossRef] [PubMed]
Sample Availability: Samples of the compound mahimbrine A are available from the authors.
Figure 1. Structure of mahimbrine A.
Figure 1. Structure of mahimbrine A.
Molecules 23 01539 g001
Figure 2. Key COSY, HMBC and NOESY correlations of mahimbrine A.
Figure 2. Key COSY, HMBC and NOESY correlations of mahimbrine A.
Molecules 23 01539 g002
Scheme 1. Proposed Biogenetic Pathway of mahimbrine A.
Scheme 1. Proposed Biogenetic Pathway of mahimbrine A.
Molecules 23 01539 sch001
Table 1. 1H and 13C NMR data for mahimbrine A (400/100 MHz, in CDCl3).
Table 1. 1H and 13C NMR data for mahimbrine A (400/100 MHz, in CDCl3).
PositionδHδCPositionδHδC
1 168.41′ 148.4
34.03, 3.90, m47.92′ 153.7
42.91, m25.83′7.04, d (9.1)114.5
4a 131.44′7.28, d (9.1)128.8
56.78, s110.64′a 129.2
6 151.85′ 148.8
7 147.96′6.74, d (2.7)133.5
86.57, s110.67′ 188.4
8a 121.98′6.87, dd (13.0, 2.7)134.9
6-OCH33.94, s56.29′8.20, d (13.0)133.6
7-OCH33.60, s56.29′a 131.5
1′-OCH33.93, s61.8
2′-OCH33.93, s56.2

Share and Cite

MDPI and ACS Style

Zhang, M.-S.; Deng, Y.; Fu, S.-B.; Guo, D.-L.; Xiao, S.-J. Mahimbrine A, a Novel Isoquinoline Alkaloid Bearing a Benzotropolone Moiety from Mahonia imbricata. Molecules 2018, 23, 1539. https://doi.org/10.3390/molecules23071539

AMA Style

Zhang M-S, Deng Y, Fu S-B, Guo D-L, Xiao S-J. Mahimbrine A, a Novel Isoquinoline Alkaloid Bearing a Benzotropolone Moiety from Mahonia imbricata. Molecules. 2018; 23(7):1539. https://doi.org/10.3390/molecules23071539

Chicago/Turabian Style

Zhang, Mao-Sheng, Yan Deng, Shao-Bin Fu, Da-Le Guo, and Shi-Ji Xiao. 2018. "Mahimbrine A, a Novel Isoquinoline Alkaloid Bearing a Benzotropolone Moiety from Mahonia imbricata" Molecules 23, no. 7: 1539. https://doi.org/10.3390/molecules23071539

Article Metrics

Back to TopTop